DUALITY S.A. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.58 PLN | +9.34% |
|
+11.66% | +6.76% |
| 20/03 | Duality S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 11/03 | BioNTech to Present Clinical Data Updates on Cancer Vaccine Candidates | MT |
| Sales 2022 | 2.14M 531K 44.29M | Sales 2023 | 5.64M 1.4M 117M | Capitalization | 5.92M 1.47M 123M |
|---|---|---|---|---|---|
| Net income 2022 | - 0 0 | Net income 2023 | -3M -745K -62.15M | EV / Sales 2022 | 5.54 x |
| Net cash position 2022 | 908K 226K 18.82M | Net cash position 2023 | 66.53K 16.52K 1.38M | EV / Sales 2023 | 1.04 x |
| P/E ratio 2022 |
24.6
x | P/E ratio 2023 |
-1.64
x | Employees | 2 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 0% |
More Fundamentals
* Assessed data
More news
| 1 day | +9.34% | ||
| 1 week | +11.66% | ||
| Current month | -1.25% | ||
| 1 month | -1.25% | ||
| 3 months | +7.48% | ||
| 6 months | -0.94% | ||
| Current year | +6.76% |
1 week
1.37
1.59
1 month
1.231.73
Current year
1.232.49
1 year
1.235.16
3 years
1.237.78
5 years
1.2310.30
10 years
1.2310.30
| Managers | Title | Age | Since |
|---|---|---|---|
| Founder | 37 | 11/17/11 | |
| Chief Executive Officer | 48 | 11/17/11 | |
Michal Szmidt
PRN | Corporate Officer/Principal | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 49 | 01/17/01 | |
Marcin Kostrzewa
CHM | Chairman | 29 | 01/19/01 |
| Founder | 37 | 11/17/11 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/24/02 | 1.69 | +6.96% | 23,573 |
| 30/24/30 | 1.58 | +9.34% | 24,098 |
| 29/24/29 | 1.445 | -2.36% | 1,497 |
| 26/24/26 | 1.48 | +1.37% | 4,904 |
| 25/24/25 | 1.46 | -0.34% | 2,972 |
End-of-day quote Warsaw S.E., April 30, 2024
More quotes- Stock Market
- Equities
- DUA Stock
